Literature DB >> 10085000

The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs.

B H Segal1, T M Doherty, T A Wynn, A W Cheever, A Sher, S M Holland.   

Abstract

Chronic granulomatous disease (CGD) is a genetic disorder of NADPH oxidase in which phagocytes are defective in generating reactive oxidants. CGD patients suffer from recurrent infections and exuberant and persistent tissue granuloma formation. We hypothesized that abnormal granulomata in CGD may result from aberrant T-cell-mediated cytokine responses. To assess Th-1-type cytokine responses and granulomata, we challenged p47(phox-/-) and wild-type mice with avirulent (SmD) or virulent (SmT) variants of Mycobacterium avium 2-151. To assess Th-2-type cytokine responses and granulomata, we used Schistosoma mansoni eggs (SME). Mononuclear cells were harvested, and cytokine responses were determined by enzyme-linked immunosorbent assay or reverse transcriptase PCR. Following SmD or SmT challenge, splenocytes from p47(phox-/-) and wild-type mice generated similar polar Th-1 responses (increased levels of gamma interferon and basal levels of interleukin 4 [IL-4] and IL-5). By 8 weeks after SmT challenge, exuberant splenic granulomata developed in p47(phox-/-) and wild-type mice. After SME challenge, thoracic lymph node mononuclear cells from p47(phox-/-) and wild-type mice generated similar mixed Th-1 and Th-2 cytokine responses to SME antigen and concanavalin A. Peak lung granuloma sizes and rates of regression were similar in p47(phox-/-) and wild-type mice. These results suggest that exuberant granulomatous inflammation in CGD is probably not the result of skewing of T-cell responses toward the Th-1 or Th-2 pole. Appropriate regression of established tissue granulomata in p47(phox-/-) mice challenged with SME suggests that abnormal granuloma formation in CGD is stimulus dependent and is not an invariant feature of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085000      PMCID: PMC96510          DOI: 10.1128/IAI.67.4.1659-1665.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia.

Authors:  T A Wynn; D Jankovic; S Hieny; A W Cheever; A Sher
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

2.  Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.

Authors:  R A Clark; S J Klebanoff
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

Review 3.  Interferon-gamma in the management of infectious diseases.

Authors:  J I Gallin; J M Farber; S M Holland; T B Nutman
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

4.  Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production.

Authors:  J D Pollock; D A Williams; M A Gifford; L L Li; X Du; J Fisherman; S H Orkin; C M Doerschuk; M C Dinauer
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

5.  Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease.

Authors:  J I Gallin; E S Buescher
Journal:  Inflammation       Date:  1983-09       Impact factor: 4.092

Review 6.  NIH conference. Recent advances in chronic granulomatous disease.

Authors:  J I Gallin; E S Buescher; B E Seligmann; J Nath; T Gaither; P Katz
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

7.  Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils.

Authors:  W R Henderson; S J Klebanoff
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

8.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

9.  The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH.

Authors:  A W Segal; M Geisow; R Garcia; A Harper; R Miller
Journal:  Nature       Date:  1981-04-02       Impact factor: 49.962

10.  An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection.

Authors:  T A Wynn; A W Cheever; D Jankovic; R W Poindexter; P Caspar; F A Lewis; A Sher
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

View more
  9 in total

1.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.

Authors:  Jacinta Bustamante; Andres A Arias; Guillaume Vogt; Capucine Picard; Lizbeth Blancas Galicia; Carolina Prando; Audrey V Grant; Christophe C Marchal; Marjorie Hubeau; Ariane Chapgier; Ludovic de Beaucoudrey; Anne Puel; Jacqueline Feinberg; Ethan Valinetz; Lucile Jannière; Céline Besse; Anne Boland; Jean-Marie Brisseau; Stéphane Blanche; Olivier Lortholary; Claire Fieschi; Jean-François Emile; Stéphanie Boisson-Dupuis; Saleh Al-Muhsen; Bruce Woda; Peter E Newburger; Antonio Condino-Neto; Mary C Dinauer; Laurent Abel; Jean-Laurent Casanova
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice.

Authors:  S A Fulton; S M Reba; T D Martin; W H Boom
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 3.  NOX enzymes and Toll-like receptor signaling.

Authors:  Eric Ogier-Denis; Sanae Ben Mkaddem; Alain Vandewalle
Journal:  Semin Immunopathol       Date:  2008-05-21       Impact factor: 9.623

Review 4.  Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?

Authors:  Rui Appelberg
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice.

Authors:  A M Cooper; B H Segal; A A Frank; S M Holland; I M Orme
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Minor role played by type I tumour necrosis factor receptor in the control of Mycobacterium avium proliferation in infected mice.

Authors:  R A Silva; M S Gomes; R Appelberg
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

7.  Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease.

Authors:  M Fujita; E Harada; T Matsumoto; Y Mizuta; S Ikegame; H Ouchi; I Inoshima; S Yoshida; K Watanabe; Y Nakanishi
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

8.  Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.

Authors:  Fons A J van de Loo; Miranda B Bennink; Onno J Arntz; Ruben L Smeets; Erik Lubberts; Leo A B Joosten; Peter L E M van Lent; Christina J J Coenen-de Roo; Salvatore Cuzzocrea; Brahm H Segal; Steven M Holland; Wim B van den Berg
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 9.  Iron in intracellular infection: to provide or to deprive?

Authors:  Sandro Silva-Gomes; Sílvia Vale-Costa; Rui Appelberg; Maria S Gomes
Journal:  Front Cell Infect Microbiol       Date:  2013-12-09       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.